Invention Grant
- Patent Title: Oxygen linked pyrimidine derivatives
- Patent Title (中): 氧联嘧啶衍生物
-
Application No.: US13438989Application Date: 2012-04-04
-
Publication No.: US08415338B2Publication Date: 2013-04-09
- Inventor: Stephanie Blanchard , Cheng Hsia Angeline Lee , Harish Kumar Mysore Nagaraj , Anders Poulsen , Eric T. Sun , Yee Ling Evelyn Tan , Anthony Deodaunia William
- Applicant: Stephanie Blanchard , Cheng Hsia Angeline Lee , Harish Kumar Mysore Nagaraj , Anders Poulsen , Eric T. Sun , Yee Ling Evelyn Tan , Anthony Deodaunia William
- Applicant Address: US WA Seattle
- Assignee: Cell Therapeutics, Inc.
- Current Assignee: Cell Therapeutics, Inc.
- Current Assignee Address: US WA Seattle
- Agency: Novak Druce Connolly Bove + Quigg LLP
- Main IPC: A61K31/33
- IPC: A61K31/33 ; C07D273/00
Abstract:
The present invention relates to pyrimidine compounds that are useful as anti-proliferative agents. More particularly, the present invention relates to oxygen linked and substituted pyrimidine compounds, methods for their preparation, pharmaceutical compositions containing these compounds and uses of these compounds in the treatment of proliferative disorders. These compounds may be useful as medicaments for the treatment of a number of proliferative disorders including tumors and cancers as well as other disorders or conditions related to or associated with kinases.
Public/Granted literature
- US20120196855A1 OXYGEN LINKED PYRIMIDINE DERIVATIVES Public/Granted day:2012-08-02
Information query
